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Background: Obesity is associated with metabolic disorders and cardiovascular diseases. This study investigated
the relationship between overweight and obese status and the incidence of type 2 diabetes, hypertension,
hyperlipidemia and hyperuricemia.
Methods: This prospective cohort study comprised 1749 hospital employees who received baseline health
check-ups in 1993. Data from the 1027 participants (832 women, 195 men; mean age, 36 ( 7 years) who
repeated check-ups in 2003 were used in the analysis. Relative risks (RRs) for development of metabolic
disorders during follow-up associated with different body mass index (BMI) categories at baseline as defined
by Asia-Pacific recommendations and the Department of Health in Taiwan were calculated after adjustment
for covariates.
Results: The prevalence of overweight and obesity at baseline check-up were 17.6% and 14.5%, respectively.
Obese subjects with baseline BMI * 25 kg/m2 had a significant multivariate-adjusted RR of 2.7 for hypertension,
14.8 for type 2 diabetes, 3.2 for hypertriglyceridemia, and 2.8 for hyperuricemia, compared to subjects with
baseline BMI < 23.0 kg/m2. RR for diabetes was higher in women than in men, but RR for hypertriglyceridemia
was higher in men. The risks of hypertension and hyperuricemia significantly increased for subjects with
baseline BMI * 23 kg/m2, while RRs for type 2 diabetes increased significantly for baseline BMI * 24 kg/m2
and hypertriglyceridemia increased for baseline BMI * 25 kg/m2. The risks attributable to obesity (baseline
BMI * 25 kg/m2) were 23.0% for hypertension, 70.8% for diabetes, 27.9% for hypertriglyceridemia, and
24.1% for hyperuricemia.
Conclusion: This study revealed that a high prevalence of overweight and obesity was associated with
significantly increased risk of development of type 2 diabetes, hypertension, hypertriglyceridemia and
hyperuricemia in hospital employees, suggesting the need for programs to improve weight management.
[J Formos Med Assoc 2006;105(1):56–63]
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Obesity, an epidemic in the industrialized world,1–3
is also a growing problem in Taiwan, with nearly
one quarter of the adult population currently over-
weight or obese.4 Obesity is generally recognized
as a major risk factor for the development of met-
abolic disorders, such as type 2 diabetes, hyper-
tension, hyperlipidemia, and hyperuricemia. As
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body mass index (BMI) rises, the relative risk (RR)
of type 2 diabetes also increases.5–10 Willett et al7
reported that for BMI > 26 kg/m2 compared to BMI
< 21 kg/m2, the risk of diabetes was four times high-
er in males in the Health Professionals Follow-up
Study,6 and eight times higher in women in the
Nurses’ Health Study.8 According to a World Health
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Physical check-up
The baseline health examination in 1993 consist-
ed of history taking, physical examination, anthro-
pometric measurements (height, body weight), and
measurements of blood pressure, fasting plasma
glucose, total cholesterol, triglyceride and uric acid.
BMI was calculated as weight in kilograms divided
by the square of the height in meters. According
to the BMI cutoffs suggested for Asians,19 subjects
were classified into normal (BMI < 23 kg/m2), over-
weight (25 > BMI * 23) or obese (BMI * 25)
categories. We also adopted the BMI cutoffs sug-
gested by the Department of Health (DOH) in Tai-
wan in order to compare results obtained using
these two definitions of excess weight. According-
ly, subjects were also classified into normal (BMI
< 24), overweight (27 > BMI * 24) or obese (BMI
* 27) categories. Venous blood was drawn after an
overnight fast and analyzed at a central laboratory
in a medical center. The health examination was
repeated in 2003.
Definitions of hypertension, type 2 diabetes,
hypercholesterolemia, hypertriglyceridemia
and hyperuricemia
Hypertension was defined according to The Sev-
enth Report of the Joint National Committee on
Prevention, Detection, Evaluation, and Treatment
of High Blood Pressure (JNC 7), i.e. systolic blood
pressure * 140 mmHg and/or diastolic blood pres-
sure * 90 mmHg, or physician-diagnosed hyper-
tension.
Diabetes was defined according to the Ameri-
can Diabetes Association criteria. Medical charts
were reviewed and a diagnosis of incident dia-
betes was confirmed if the subject met any one of
the following criteria: (1) fasting plasma glu-
cose level of at least 126 mg/dL and 2-hour post-
prandial plasma glucose level of at least 200
mg/dL; (2) elevated fasting plasma glucose level
(* 126 mg/dL) on at least two different occasions;
(3) treatment with hypoglycemic medication.
Hyperlipidemia was defined as serum total cho-
lesterol * 240 mg/dL and/or triglyceride * 200 mg/
dL. Hyperuricemia was defined as serum uric acid
* 7.5 mg/dL for men and * 6.5 mg/dL for women.
Organization report, the risks for type 2 diabetes
and dyslipidemia are greatly increased in obese
subjects, with RR > 3.0.10
Previous studies have demonstrated that the
prevalence of hypertension increases with the de-
gree of overweight.11,12 Prospective investigation
revealed an association between BMI > 20 kg/m2
and increased incidence of hypertension in
Japanese men.13 The Finnish Heart Study found
that higher BMI increased the risk of coronary
mortality that was mediated through the link be-
tween body weight and blood pressure.14 Obesity
is also associated with hypertriglyceridemia.
Further, abdominal obesity and high serum
triglyceride levels are associated, a phenotypic
characteristic known as the hypertriglyceridemic
waist.15 Positive cross-sectional associations be-
tween hyperuricemia and overweight have also
been demonstrated for adult males in Taiwan and
Japan.16–18
There has been a lack of prospective investi-
gation exploring the relationship between obes-
ity and the incidence of metabolic disorders
related to cardiovascular diseases in Taiwan.
The present study examined a cohort of hospital
employees to determine the association between
BMI and incidence of obesity-related metabolic
disorders.
Methods
Subjects
Participants were employees of a teaching hos-
pital in Taipei, Taiwan. In 1993, 1749 employees
(> 20 years old) who had regular physical check-
ups were recruited. Subjects who were pregnant
at baseline, or who left work during the follow-up
period, were excluded. A total of 1027 employees
who worked full-time at the hospital throughout
the 10.5-year study period (9.7–10.7) completed
both the baseline check-up in 1993 and follow-up
check-up in 2003. There were no significant dif-
ferences at baseline between the study group and
those with loss of follow-up in age, sex, BMI and
prevalence of metabolic disorders.
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Statistical analysis
SAS software (SAS Institute Inc, Cary, NC, USA)
was used for all statistical analyses. The demograph-
ic characteristics of subjects were compared at the
baseline health check-ups in 1993 and at the fol-
low-up health check-ups in 2003 using the paired
t test. In addition, for all incident analyses, preva-
lent cases of the specific outcome were excluded
(e.g. cases of diabetes in 1993 were excluded from
analyses of the incidence of diabetes). Differences
in proportion data were assessed using the chi-
square test. Multiple logistic regression was used
to derive the RRs and 95% confidence intervals
(CIs) to determine the 10-year risk of overweight
and obesity for developing high cholesterol and/
or triglyceride levels, hypertension, type 2 diabetes,
and hyperuricemia. All logistic regression models
were adjusted for age, sex, smoking status, alcohol
intake and BMI change. The population attributa-
ble risk (PAR) was calculated using Levin’s formula:
PAR = P0(RR – 1)/P0(RR – 1) + 1; where P0 is the
proportion of the exposed population. All p val-
ues are 2-sided, with p less than 0.05 considered
to be statistically significant. Means are presented
with standard deviations.
Results
Table 1 summarizes the clinical characteristics at
the start of this study in 1993 and at the end of the
study in 2003 for the 1027 subjects with complete
follow-up. At the time of the baseline health check-
ups in 1993, mean age was 33.5 ( 7.2 years (range,
21–56 years). Mean BMI was 23.8 kg/m2 for men
and 21.6 kg/m2 for women. The baseline preva-
lence of type 2 diabetes, hypertension, hyper-
cholesterolemia, triglyceridemia and hyperuri-
cemia was 1.0%, 12.9%, 3.2%, 3.5% and 5.9% in
1993, respectively, and all were more common in
men than in women.
At the follow-up health check-ups in 2003, fast-
ing plasma glucose, systolic blood pressure, serum
cholesterol and triglyceride levels, but not diastol-
ic blood pressure, were increased significantly,
as determined by paired t test. A diagnosis of high
Table 1.  Clinical characteristics of subjects (n = 1027) at baseline and 10.5 years later
Baseline (1993) 10.5 years later (2003)
Total Women Men Total Women Men
Age (yr) 33.5 ( 7.2 32.6 ( 7.1 37.3 ( 6.4 44.0 ( 7.1 43.1 ( 7.0 47.7 ( 6.3
Fasting plasma glucose (mg/dL) 090.0 ( 14.8 089.0 ( 14.2 094.2 ( 16.2 093.8 ( 19.2 092.9 ( 19.6 097.7 ( 16.8
BMI (kg/m2) 22.0 ( 2.9 21.6 ( 2.8 23.8 ( 2.9 23.1 ( 3.4 22.7 ( 3.4 24.8 ( 2.9
Systolic blood pressure (mmHg) 114.1 ( 14.1 112.7 ( 14.2 119.8 ( 11.9 121.9 ( 18.5 120.1 ( 18.7 129.9 ( 14.9
Diastolic blood pressure (mmHg) 76.0 ( 9.4 75.1 ( 9.4 80.2 ( 8.3 071.9 ( 11.7 070.3 ( 11.3 078.9 ( 10.7
Total cholesterol (mg/dL) 181.9 ( 32.5 178.9 ( 31.3 190.0 ( 34.4 186.1 ( 32.5 183.9 ( 32.5 195.7 ( 30.8
Triglyceride (mg/dL) 090.2 ( 59.2 088.9 ( 44.9 125.0 ( 77.9 090.6 ( 84.7 080.5 ( 76.3 0133.8 ( 103.6
Uric acid (mg/dL) 05.1 ( 1.5 04.7 ( 1.3 6.4 ( 1.4 05.6 ( 1.5 05.3 ( 1.3 07.2 ( 1.4
Prevalence
Type 2 diabetes (%) 1.0 1.0 1.0 3.3 2.9 4.6
Hypertension (%) 12.90 10.70 22.10 20.40 17.20 33.90
Hypercholesterolemia (%) 3.2 2.2 7.7 6.4 5.1 12.30
Hypertriglyceridemia (%) 3.5 1.2 11.80 6.7 4.6 16.40
Hyperuricemia (%) 5.9 3.3 17.40 20.30 15.40 41.00
Overweight (%), 25 > BMI * 23 17.60 14.40 31.30 19.80 17.20 30.80
Obesity (%), BMI * 25 14.50 11.10 29.20 24.70 20.20 44.10
Overweight (%), 27 > BMI * 24 16.60 12.40 34.40 21.10 17.40 36.90
Obesity (%), BMI * 27 6.1 5.1 10.80 12.50 10.60 20.50
Data are presented as mean ( standard deviation or %. BMI = body mass index.
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blood pressure was made in more than one fifth
of subjects. Type 2 diabetes developed in approxi-
mately 2.3% of subjects. Among them, 90.9%
(30/33) used hypoglycemia medications. Among
subjects with hypertension, 54.1% (112/207) used
antihypertensive medications in 2003. The pre-
valence of hypercholesterolemia and triglyceri-
demia had doubled at the follow-up health check-
ups. Hyperuricemia was also significantly more
prevalent at the follow-up in 2003 (5.9% vs.
20.3%).
Mean baseline BMI was 22.0 ( 2.9, with 67.9%
of the subjects in the normal range, 17.6% over-
weight, and 14.5% obese according to Asia-Pacific
recommendations, and 16.6% overweight and
6.1% obese according to DOH Taiwan criteria. Ex-
cessive weight was more common in men than in
women. At the 10.5-year follow-up, the prevalence
of overweight had increased by 2.2–4.5% and
the prevalence of obesity had doubled. Further,
the prevalence of BMI * 30 rose from 1.5% to
4.7%.
The cumulative incidence of type 2 diabetes,
hypertension, hypertriglyceridemia and hyper-
uricemia, but not hypercholesterolemia, increased
progressively with higher baseline BMI (Table 2)
as defined by either the Asia-Pacific or DOH
criteria. Most metabolic disorders, such as type 2
Table 2. Cumulative incidence of obesity-related metabolic disorders at the 10.5-year follow-up by baseline body
mass index (BMI) categories
Baseline BMI categories (kg/m2) by Asian criteria Baseline BMI categories (kg/m2) by DOH
< 23 23–24.9 * 25 p < 24 24–26.9 * 27 p
Total
n (%) 697 (67.9) 181 (17.6) 149 (14.5) 794 (77.3) 170 (16.6) 63 (6.1)
Type 2 diabetes (%) 00.7 01.7 11.0 * 00.8 03.6 20.0 *
Hypertension (%) 10.2 25.4 31.4 * 12.0 25.2 40.5 *
Hypercholesterolemia (%) 04.1 08.4 07.1 † 04.8 07.1 06.9
Hypertriglyceridemia (%) 03.3 07.1 13.1 * 03.7 07.8 20.4 *
Hyperuricemia (%) 12.4 24.6 33.3 * 13.6 30.6 31.3 *
Any one of the above (%) 25.9 45.2 60.0 * 27.5 50.8 60.6 *
Any two or more of the above (%) 5.1 14.7 22.9 * 08.5 25.9 45.8 *
Men
n (%) 77 (39.5) 61 (31.3) 57 (29.2) 107 (54.9) 67 (34.4) 21 (10.8)
Type 2 diabetes (%) 1.33 03.3 07.1 † 01.9 03.0 15.0 *
Hypertension (%) 21.4 30.9 40.0 † 23.7 35.6 42.9 †
Hypercholesterolemia (%) 08.1 14.3 08.0 09.6 10.2 11.8
Hypertriglyceridemia (%) 06.6 10.0 23.9 † 07.0 14.3 37.5 †
Hyperuricemia (%) 23.3 40.8 43.6 † 28.6 44.9 28.6
Any one of the above (%) 46.4 63.4 70.0 † 50.6 67.5 66.7 †
Any two or more of the above (%) 24.5 40.0 57.1 * 26.2 53.6 50.0 †
Women
n (%) 620 (74.5) 120 (14.4) 92 (11.1) 687 (82.6) 103 (12.4) 42 (5.1)
Type 2 diabetes (%) 00.7 00.8 13.5 * 00.6 03.9 22.5 *
Hypertension (%) 08.8 23.0 26.2 * 10.3 19.5 39.1 *
Hypercholesterolemia (%) 03.6 05.5 06.6 4.0 05.2 04.9
Hypertriglyceridemia (%) 02.9 05.9 07.1 † 03.2 04.1 13.2 †
Hyperuricemia (%) 11.1 17.8 28.4 * 11.4 23.5 32.4 *
Any one of the above (%) 22.9 35.6 54.6 * 24.3 42.7 58.3 *
Any two or more of the above (%) 05.0 16.7 26.8 * 06.5 11.3 44.4 *
*p < 0.0001, †p < 0.05 (Cochran-Armitage Trend Test). DOH = Department of Health, Taiwan.
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diabetes, hypertension, hypertriglyceridemia and
hyperuricemia (except hypercholesterolemia), oc-
curred in parallel with increasing baseline BMI in
both genders. The incidences of these metabolic
disorders were significantly higher in men than in
women. Subjects with BMI < 23 at baseline had
the lowest rates of metabolic disorders at follow-
up. In contrast, nearly 60% of subjects who were
obese at baseline developed more than one meta-
bolic disorder. The cumulative follow-up incidence
of type 2 diabetes, hypertension, hypercholes-
terolemia, hypertriglyceridemia and hyperurice-
mia in subjects who were obese at baseline accord-
ing to the Asia-Pacific criteria was 11.0%, 31.4%,
7.1%, 13.1% and 33.3%, respectively. Two or more
metabolic disorders were found in 22.9% of
subjects who were obese at baseline, but in only
5.1% of subjects with normal weight.
Multivariate analysis with adjustment for age,
sex, smoking, alcohol intake and BMI change
demonstrated that obese subjects were at signifi-
cantly increased risk of developing type 2 diabetes,
hypertension, hypertriglyceridemia and hyper-
uricemia, compared to subjects with normal BMI
(Table 3). The odds ratio for type 2 diabetes was
higher in women, but the odds ratio for hyper-
triglyceridemia was higher in men. The population
attributable proportion (PAP) for obesity was
Table 3.  Effect of baseline body mass index (BMI) categories on risk of subsequent metabolic disorders*
Baseline BMI categories (kg/m2) by Asian criteria Baseline BMI categories (kg/m2) by DOH
< 23 23–24.9 * 25 < 24 24–26.9 * 27
RR PAR RR PAR RR PAR RR PAR
RR
(95% CI) (%) (95% CI) (%)
RR
(95% CI) (%) (95% CI) (%)
Total
Type 2 diabetes  1 2.2 (0.5–9.4) 19.8 14.8 (5.0–43.6) 70.8 1 03.9 (1.2–13.0) 32.4 27.9 (9.7–80.3) 61.3
Hypertension 1 2.4 (1.5–3.9) 22.4 2.7 (1.6–4.5) 23.0 1 1.6 (1.0–2.6) 07.9 4.0 (1.9–8.4) 11.0
Hypercholesterolemia 1 1.7 (0.8–3.9) 12.6 1.4 (0.6–3.1) 06.6 1 1.1 (0.5–2.3) 01.5 1.2 (0.4–3.4) 01.1
Hypertriglyceridemia 1 1.8 (0.9–3.8) 14.2 3.2 (1.6–6.5) 27.9 1 1.5 (0.7–3.2) 07.2 05.5 (2.5–11.9) 19.8
Hyperuricemia 1 1.8 (1.2–2.8) 14.2 2.8 (1.7–4.5) 24.1 1 2.1 (1.4–3.3) 14.3 2.4 (1.2–4.8) 06.5
Any one of the above 1 1.7 (1.2–2.6) – 3.0 (1.9–4.9) – 1 1.9 (1.2–2.8) – 3.8 (1.7–8.1) –
Any two or more of the above 1 2.7 (1.5–5.0) – 5.0 (2.6–9.9) – 1 2.1 (1.1–4.1) – 08.2 (3.1–21.4) –
Men
Type 2 diabetes 1 02.4 (0.2–28.1) 30.3 04.2 (0.4–42.9) 48.1 1 01.3 (0.2–10.1) 09.3 06.7 (0.9–49.2) 37.1
Hypertension 1 1.6 (0.7–3.9) 14.2 2.4 (1.1–5.8) 26.9 1 1.8 (0.8–3.9) 19.2 2.5 (0.7–8.5) 12.1
Hypercholesterolemia 1 2.1 (0.6–6.7) 25.5 1.0 (0.2–3.2) 00.0 1 1.0 (0.3–3.2) 00.0 0.7 (0.1–4.2) 02.9
Hypertriglyceridemia 1 1.7 (0.5–6.2) 16.9 05.1 (1.6–16.3) 52.3 1 2.5 (0.8–7.4) 32.8 ..8.9 (2.4–33.8) 42.3
Hyperuricemia 1 2.2 (1.0–4.9) 26.7 2.9 (1.2–6.8) 31.5 1 2.3 (1.1–4.9) 28.3 1.2 (0.3–4.4) 01.7
Any one of the above 1 1.9 (0.9–4.3) – 2.6 (1.1–6.6) – 1 2.0 (0.9–4.5) – 1.9 (0.4–8.1) –
Any two or more of the above 1 2.1 (0.7–5.9) – 04.1 (1.4–12.2) – 1 3.3 (1.3–8.5) – 02.8 (0.5–15.5) –
Women
Type 2 diabetes 1 01.2 (0.2–10.5) 02.8 19.1 (5.7–63.7) 66.1 1 05.5 (1.3–23.0) 35.7 040.4 (11.5–143). 65.6
Hypertension 1 2.9 (1.7–5.2) 20.3 2.4 (1.2–4.6) 10.9 1 1.5 (0.8–2.8) 05.2 04.5 (1.7–11.6) 09.8
Hypercholesterolemia 1 1.4 (0.5–3.5) 05.1 1.5 (0.6–3.9) 05.2 1 1.0 (0.4–2.8) 00.0 1.0 (0.3–4.3) 00.0
Hypertriglyceridemia 1 1.9 (0.8–4.6) 11.5 2.0 (0.7–5.4) 09.3 1 1.1 (0.3–3.2) 01.2 03.6 (1.2–10.6) 10.8
Hyperuricemia 1 1.6 (0.9–2.7) 08.1 2.5 (1.4–4.4) 13.1 1 1.9 (1.1–3.4) 09.9 3.0 (1.4–6.7) 07.8
Any one of the above 1 1.6 (1.0–2.6) – 3.1 (1.8–5.4) – 1 1.7 (1.1–2.9) – 04.4 (1.8–10.9) –
Any two or more of the above 1 2.9 (1.4–6.3) – 04.9 (2.0–11.6) – 1 1.3 (0.5–3.4) – 10.8 (3.4–34.7) –
*Multiple logistic regression model: adjusted for age, gender, smoking status, alcohol intake and BMI change over the 10.5-year period. DOH = Department
of Health, Taiwan; RR = relative risk; CI = confidence interval; PAR = population attributable risk.
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70.8% for type 2 diabetes, 23.0% for hypertension,
27.9% for hypertriglyceridemia, and 24.1% for
hyperuricemia.
Subjects who were overweight at baseline as
defined by the Asia-Pacific criteria were at signifi-
cantly increased risk for hypertension (RR = 2.4)
and hyperuricemia (RR = 1.8) during follow-up.
Overweight subjects as defined by DOH criteria
were also at increased risk for type 2 diabetes. No
relationship was found between baseline BMI cat-
egories and incidence of hypercholesterolemia at
follow-up in the multivariate analysis.
During the follow-up period, risk of develop-
ment of any one or two of the metabolic disorders
increased significantly with higher baseline BMI
categories.
Discussion
This 10.5-year follow-up study has confirmed
that the risk of metabolic disorders related to car-
diovascular diseases increases progressively
with higher baseline BMI regardless of whether
Asia-Pacific or DOH criteria are used to define BMI
categories. Further, the risks of hypertension and
hyperuricemia were significantly increased for
baseline BMI * 23, while risk of type 2 diabetes
increased significantly for baseline BMI * 24, and
risk of hypertriglyceridemia increased for baseline
BMI * 25.
As BMI increases, the RR of developing diabe-
tes increases for both genders in many ethnic
groups.5–10 The risk was lowest when BMI was < 22
and 24 in the Nurses’ Health Study8 and the Health
Professionals Follow-Up Study, respectively.6 Tai
et al found that the risk for diabetes in Chinese
men with BMI > 25.3 was 2.9 times higher than
for those with BMI < 21.3.9 Our findings showing
a strong relationship between obesity in adult-
hood and subsequent risk for type 2 diabetes over
a 10.5-year period are consistent with previous
research. The lowest risk for diabetes in this study
was for subjects with BMI < 23, who had a 14-fold
lower risk relative to their counterparts with BMI
* 25. Using DOH criteria, the risk of diabetes was
significantly increased in overweight subjects with
BMI 24–26.9.
As BMI increases, the RR of hypertension also
progressively increases.11,12 Previous study in a
cohort of Japanese men revealed that, for BMI
above 20 kg/m2, increased BMI was associated
with an increased risk for hypertension.13 The
Finnish Heart Study, a 15-year follow-up study
performed in a cohort of 8373 Finnish women
aged 30–59 years, found that for each increase
in body weight of approximately 1 kg, the risk of
coronary mortality increased by 1–1.5% that
was mediated through the link between body
weight and blood pressure.14 This study demon-
strated that, for BMI above 23 kg/m2, an increase
in baseline BMI was associated with increased
risk of hypertension, a BMI threshold lower than
that for diabetes. Development of hypertension
was attributable to overweight or obesity in 45%
of cases. Obesity is also associated with hyper-
triglyceridemia.15,20,21 In this study, obesity was as-
sociated with an increased risk of developing hy-
pertriglyceridemia in subjects with normal base-
line triglyceride levels.
Positive cross-sectional associations have been
demonstrated between hyperuricemia and over-
weight in adult males from Taiwan and Japan.16–18
Hyperinsulinemia induced by insulin resistance
reduces uric acid clearance, leading to hyperuri-
cemia, with accumulation of visceral fat exacerbat-
ing the problem by increasing uric acid synthesis
through the activation of triglyceride synthesis.18
This study has shown that, for BMI > 23 kg/m2,
increased BMI is associated with increased hyper-
uricemia risk in subjects who had normal serum
uric acid levels 10 years previously. Compared with
subjects who had baseline BMI < 23, subjects who
were overweight at baseline had a 1.8-fold in-
creased risk of hyperuricemia, and obese subjects
had a 2.8-fold increased risk at the 10.5-year fol-
low-up. Further, 38.3% of hyperuricemia develop-
ment was attributable to overweight or obese status
at baseline.
The mechanisms leading to metabolic disor-
ders associated with cardiovascular disease in
obese persons are not completely known. It has
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been hypothesized, however, that increased in-
sulin resistance and hyperinsulinemia are contri-
butors,22,23 and both of these are reversible with
weight loss.24 Obesity affects metabolic disorders
by the increased secretion of free fatty acids from
fat and reduced production of adiponectin, which
induce the insulin-resistant state, hyperinsuline-
mia, and diabetes and/or development of other
metabolic disorders.25 Hypertension may also de-
velop due to sympathetic nervous system hyper-
activity, and renal sodium reabsorption mediated
by hyperinsulinemia. Hyperinsulinemia increases
hepatic very low density lipoprotein, and trigly-
ceride synthesis and secretion, which are associat-
ed with hypertriglyceridemia.
The optimal weight for avoidance of cardiovas-
cular disease and prolongation of life remains con-
troversial. In the Framingham Heart Study, each
standard deviation increment in relative weight
was associated with 15% and 22% increases in
cardiovascular events in men and women, respec-
tively, during 26 years of follow-up.26 Kannel et al
suggested that the optimal weight for avoidance
of cardiovascular disease and prolonging life cor-
responds to a BMI of 22.6 for men and 21.1 for
women. Analyzing data from the Nurses’ Health
Study8 and the Health Professionals Follow-up
Study,6 Field et al demonstrated that adults in the
healthy weight range (BMI 22–24.9) incurred an
increased risk for non-communicable chronic dis-
eases.27 They suggested that adults should try to
maintain a BMI between 18.5 and 21.9. A study
from Japan found that the BMI associated with
the lowest morbidity was 22.2 in men and 21.9 in
women.28 In this study, increased risks of develop-
ing metabolic disorders were found for subjects
with baseline BMI > 23. The high prevalence of
BMI greater than this level suggests the need for
greater awareness and prevention of metabolic dis-
orders related to overweight or obesity.
In conclusion, this study has demonstrated that
excess BMI in adulthood increases the risk of de-
veloping type 2 diabetes, hypertension, hyper-
triglyceridemia and hyperuricemia. These results
indicate the need for weight management programs
in adults.
References
1. Mokdad AH, Ford ES, Bowman BA. Prevalence of obesity,
diabetes, and obesity-related health risk factors, 2001.
JAMA 2003;289:76–9.
2. Silventoinen K, Sans S, Tolonen H, et al. Trends in obesity
and energ supply in the WHO MONICA Project. Int J Obes
Relat Metab Disord 2004;28:710–8.
3. Flegal KM, Carroll MD, Ogden C, et al. Prevalence and
trends in obesity among US adults, 1999–2000. JAMA
2002;288:1723–7.
4. Lin YC, Yen LL, Chen SY, et al. Prevalence of overweight and
obesity and its associated factors: findings from National
Nutrition and Health Survey in Taiwan, 1993–1996. Prev
Med 2003;37:233–41.
5. Colditz GA, Willett WC, Rotnitzky A, et al. Weight gain as a
risk factor for clinical diabetes mellitus in women. Ann
Intern Med 1995;122:481–6.
6. Chan JM, Rimm EB, Colditz GA, et al. Obesity, fat distribution,
and weight gain as risk factors for clinical diabetes in men.
Diabetes Care 1994;17:961–9.
7. Willett WC, Dietz WH, Colditz GA: Guidelines for healthy
weight. New Engl J Med 1999;341:427–34.
8. Carey VJ, Walters EE, Colditz GA, et al. Body fat distribution
and risk of non-insulin-dependent diabetes mellitus in
women. The Nurses’ Health Study. Am J Epidemiol 1997;
145:614–9.
9. Tai T, Chuang L, Wu H, et al. Association of body build with
non-insulin-dependent diabetes mellitus and hypertension
among Chinese adults: a 4-year follow-up study. Int J
Epidemiol 1992;21:511–7.
10. World Health Organization. The health consequences of
overweight and obesity in adults and children. In: Obesity,
Preventing and Managing the Global Epidemic. Geneva:
WHO, 1998:43–72.
11. Must A, Spadano J, Coakley EH, et al. The disease burden
associated with overweight and obesity. JAMA 1999;282:
1523–9.
12. Brown CD, Higgins M, Donato KA, et al. Body mass index
and the prevalence of hypertension and dyslipidemia. Obes
Res 2000;8:605–19.
13. Ishikawa-Takata K, Ohta T, Moritaki K, et al. Obesity,
weight change and risks for hypertension, diabetes and
hypercholesterolemia in Japanese men. Eur J Clin Nutr
2002;56:601–7.
14. Jousilahti P, Tuomilehto J, Vartiainen E, et al. Body weight,
cardiovascular risk factors, and coronary mortality. 15-year
follow-up of middle-aged men and women in eastern
Finland. Circulation 1996;93:1372–9.
15. Little P, Byrne CD. Abdominal obesity and the “hypertri-
glyceridaemic waist” phenotype. BMJ 2001;322:687–9.
16. Chu NF, Wang DJ, Liou SH, et al. Relationship between hy-
peruricemia and other cardiovascular disease risk factors
among adult males in Taiwan. Eur J Epidemiol 2000;16:
63J Formos Med Assoc | 2006 • Vol 105 • No 1
Impact of body mass index on metabolic disorders
13–7.
17. Nagahama K, Iseki K, Inoue T, et al. Hyperuricemia and
cardiovascular risk factor clustering in a screened cohort in
Okinawa, Japan. Hypertens Res 2004;27:227–33.
18. Lai SW, Ng KC. Which anthropometric indices best predict
metabolic disorders in Taiwan? Southern Med J 2004;97:
578–82.
19. Kanazaawa M, Yoshiike N, Osaka T, et al. Criteria and clas-
sification of obesity in Japan and Asia-Oceania. Asia Pac
Clin Nutr 2002;11:S732–7.
20. Siervogel RM, Wisemandle W, Maynard LM. Lifetime
overweight status in relation to serial changes in body
composition and risk factors for cardiovascular disease: The
Fels Longitudinal Study. Obes Res 2000;8:422–30.
21. Rabkin SW, Chen Y, Leiter L. Risk factor correlates of body
mass index. Can Med Assoc J 1997;157:S26–31.
22. Reaven GM. Role of insulin resistance in human disease.
Diabetes 1988;37:1595–607.
23. George AB. Medical consequences of obesity. J Clin
Endocrinol Metab 2004;89:2583–9.
24. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of
type 2 diabetes mellitus by changes in lifestyle among
subjects with impaired glucose tolerance. N Engl J Med
2001;344:1343–50.
25. Goldstein BJ, Scalia R. Adiponectin: a novel adipokine
linking adipocytes and vascular function. J Clin Endocrinol
Metab 2004;89:2563–8.
26. Kannel WB, D’Agostino RB, Cobb JL. Effect of weight on
cardiovascular disease. Am J Clin Nutr 1996;63(3 Suppl):
S419–22.
27. Field AE, Coakley EH, Must A, et al. Impact of overweight
on the risk of developing common chronic diseases during
a 10-year period. Arch Intern Med 2001;161:1581–6.
28. Tokunaga K, Matsuzawa Y, Kotani K, et al. Ideal body
weight estimated from the body mass index with the lowest
morbidity. Int J Obes 1991;15:1–5.
